EVISA Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Helicobacter


 

Status
active
Indexing
Current Contents/Clinical Medicine; Medical Documentation Service; Research Alert; Sci Search;
Science Citation Index; Medline
Subject

Source type
Journal
Publisher
ISBN ISSN
1083-4389
E ISSN
1523-5378
First volume
1
Last volume
13+
Publish city
Cambridge, Mass.
Homepage
Description

Helicobacter recognises the critical role that has been established for Helicobacter pylori in peptic ulcer, gastric adenocarcinoma, and primary gastric lymphoma. As new helicobacter species are now regularly being discovered, Helicobacter covers the entire range of helicobacter research, increasing communication among the fields of
• gastroenterology
• microbiology
• vaccine development
• laboratory animal science.

New discoveries in molecular biology and clinical trials of new treatment open up a wide range of possibilities for patient care and cure - Helicobacter will be there to report the results.













Imprint     Disclaimer

© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )